Follow The Filings

NVS Novartis

Health Care, filed as NOVARTIS AG (SPONSORED ADR), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2, sold by 2

  • 1 Owner
  • #139
  • Max 0.7%
  • Master 0.01%
  • $1.4M
  • 1 reduce

In 2026 Q3 Kentucky Trust trimmed Novartis.

Who owns this now

Largest portfolio weights among holders, up to 0.7% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. Reduce 0.70%

Who owns NVS

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.70%, was 0.78% Reduce −5.0% 9,800 $1.4M History

Weight bar: held both quarters added sold at this quarter’s reported price

Congress

5 members of Congress traded NVS in the last three years: 7 buys and 8 sales. 8 members listed it in 2025 annual reports.

All Congress trades
  1. Kevin Hern R-OK-1 Sell $15K–$50K Aug 27 filed Sep 25
  2. Alan Armstrong R-OK Buy $1K–$15K Mar 31 filed Jul 21
  3. Alan Armstrong R-OK Buy $15K–$50K Mar 30 filed Jul 21
  4. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 31, 2025 filed Nov 21, 2025
  5. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 30, 2025 filed Nov 21, 2025
  6. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Oct 30, 2025 filed Nov 21, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K
6-K FORM 6-K
6-K
6-K FORM 6-K
424B5
424B5
20-F
6-K
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
424B5
424B5
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G —
6-K

Financials

US-GAAP annual figures, as tagged in Form 10-K

Newly public, no 10-K financials yet. See the 424B5.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.